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T h eU n i v e r s i t yo fT e n n e s s e e( U T ) ,t h eO a kR i d g e
National Laboratory (ORNL), and the Kentucky Biome-
dical Research Infrastructure Network (KBRIN), have
collaborated over the past decade to share research and
educational expertise in bioinformatics. One result of
this collaboration is the joint sponsorship of an annual
regional summit to bring together researchers, educators
and students who are interested in bioinformatics from
a variety of research and educational institutions. This
summit provides unique opportunities for collaboration
and forging links between members of the various insti-
tutions. This year, the Tenth Annual UT-ORNL-KBRIN
Bioinformatics Summit was held at the University of
Memphis in Memphis, Tennessee from April 1-3, 2011.
A total of 225 participants pre-registered for the sum-
mit, with 146 from various Tennessee institutions and
60 from various Kentucky institutions. A number of
additional participants came from universities and
research institutions from other states and countries, e.
g. University of Arkansas Medical Sciences, University
of British Columbia, University of Cincinnati, Iowa State
University, etc. Seventy-four registrants were faculty,
with an additional 73 students, 50 staff, and 28 postdoc-
toral participants.
The conference program consisted of three days of
presentations. The first day included a pre-summit of
talks by researchers supported by the Kentucky Biome-
dical Research Infrastructure Network (KBRIN), and
three workshops covering the topics Next-Generation
Sequencing, the workflow platform Galaxy, and Gene-
MANIA. The next two days were dedicated to scientific
presentations divided into three plenary sessions on
Pediatric Genetics, Pharmacogenomics and Systems
Biology. Each session also included short talks selected
from the submitted poster abstracts.
Pre-summit KBRIN session
Dr. Eric Rouchka started the pre-summit KBRIN session
with an update on the supplement to the primary
KBRIN grant awarded in 2009. Thanks to the funding
provided by the supplement, five postdoctoral research
associates have been hired, along with two masters level
bioinformatics staff positions. In addition, a weekly
seminar series has been implemented that includes
externally invited speakers with strong research pro-
grams in bioinformatics.
Following was a series of short talks from various Uni-
versity of Louisville researchers: “Developing an Analysis
Pipeline for FT-ICR-MS Isotop o l o g u eD a t af r o mS t a b l e
Isotope Resolved Metabolomics (SIRM) Experiments”
(Hunter Moseley), “Time Series Classifier Model for
miR-mRNA Relationships” (Jovan D. Rebolledo-Men-
dez), “Assessing Variations in NGS Data” (Alex Kem-
per), “A Systems Based Approach to Find Protein
Interactions Across Tissues” (Fahim Mohammad), “cate-
goryCompare: High-Throughput Data Meta-Analysis
Using Gene Annotations” (Robert M. Flight), “Colla-
borations between Biology/Bioinformatics” (Benjamin J.
Harrison).
Friday workshops
Jon Armstrong of Cofactor Genomics (St. Louis, MO;
http://www.cofactorgenomics.com) started the official
summit program with an excellent overview of the past,
present and future of DNA sequencing, beginning with
the Maxam-Gilbert [1] and Sanger [2] methods and
transitioning to the approaches used by next-generation
sequencers. Among the technologies covered were pyro-
sequencing [3], reversible dye terminator technology [4],
sequencing by ligation [5], and single molecule real time
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nologies, he also sought to explain what types of experi-
ments are best suited for each NGS platform, based on
the strengths and weaknesses of each technology. Given
the rapidly growing number of NGS machines available,
the information was extremely useful for both those
planning NGS experiments and those analyzing the
resulting data.
Following up, Dr. James Taylor from Emory University
gave a workshop on the workflow system GALAXY
[7,8]. Dr. Taylor started with a comprehensive explana-
tion of the many research issues motivating the develop-
ment of GALAXY as an easily modifiable, reproducible
workflow system for both biologists and bioinformati-
cians working with high-throughput data. He then pro-
ceeded to explain and demonstrate many of GALAXY’s
features by performing real world analyses using data
from the UCSC genome browser [9]. Notable features
include the ability to share workflows with others, the
ability to generate results pages (similar to full blown
publications) with workflows embedded in the docu-
m e n ta n da c c e s s i b l et oa n y o n ev i e w i n gt h ep a g e ,a n d
the recent ability for NGS core lab implementations to
couple sample requests to workflows so that data pro-
cessing can occur as soon as the data becomes available.
As a final note, Dr. Taylor also demonstrated how easy
it is to set up GALAXY instances in Amazons EC2
cloud computing system, enabling one to take advantage
of cloud computing systems [10].
The final workshop was given by Dr. Quaid Morris
from the University of Toronto on the use of GeneMA-
NIA [11] for pathway and network analysis. GeneMA-
NIA uses gene association networks to assign probable
functions of genes based on guilt by association: those
genes that share connections (annotations or interac-
tions) probably share other attributes as well. GeneMA-
NIA is available either as a Cytoscape plugin [12,13] or
on the web.
Session I: pediatric genetics
The first session began with opening remarks by Dr.
Ramin Homayouni from the University of Memphis. Dr.
Homayouni provided a 10 year retrospective of the sum-
mit, its beginnings and growth, and the many collabora-
tions and new bioinformatic tools that have resulted
from those attending the conference.
The Pediatric Genetics session was truly underway
with Dr. Hakon Hakonarson of The Children’s Hospital
of Philadelphia discussing his research on determining
the genetic underpinnings of complex pediatric disor-
ders. As a way to try and cope with the large number of
rare genetic variants and their combinations that lead to
disease, his group at the Center for Applied Genomics
at Children’s Hospital of Philadelphia (CHOP) is
targeting to genotype 100,000 children over a five year
period making use of a biorepository. One of the goals
of this project is to link the genotypes to electronic
health care records for the purpose of tying together
genotype and phenotype information. Using this data,
they have determined SNPs involved in a number of dif-
ferent diseases, including juvenile (Type I) diabetes
[14-27], neuroblastoma [28-30] and autism spectrum
d i s o r d e r[ 3 1 - 3 5 ] .T h e yh o p et ob ea b l et ou s et h i sa sa
retrospective tool to determine the causes of many
other diseases as well.
Following up on that, Dr. Jun Yang from St. Jude
Children’s Research Hospital presented work on phar-
macogenomics and racial disparities in childhood acute
lymphoblastic leukaemia [36]. Especially compelling was
the ability to use a set of genome wide SNPs to define
racial ancestry. These same SNPs also provided a large
amount of power in explaining a child’s probability of
survival of ALL. In addition to measuring the overall
survival probability, Dr. Yang discussed how this infor-
mation is being used to predict relapse and response to
five drugs: DNA, ASP, Chcb, AraC, and 6-TG.
Session II: pharmacogenomics
Starting the session on pharmacogenomics, Dr. Josh
Denny from Vanderbilt University presented work on
using electronic medical records for discovery and vali-
dation in genome science as part of the eMERGE Net-
work [37]. His group has concentrated on coupling
Vanderbilt’s opt-out biobank where samples are geno-
typed for high-value SNPs, with phenotypes generated
through text-mining of associated electronic medical
records. Specifically, Dr. Denny has interest in genotyp-
ing SNPs in 10,000 samples across 21 loci implicated in
atrial fibrulation, Crohn’s disease, type II diabetes, multi-
ple sclerosis, and rheumatoid arthritis. Highlighted chal-
lenges in using electronic medical records were
presented, included the diagnosis of diseases for which
treatment is covered by insurance but which the patient
did not have, and the use of templates in doctor’s offices
that result in non-informative field descriptions [38].
Both of these proved to be difficult for natural language
processing. Dr. Denny discussed case studies of using
the Vanderbilt Electronic Systems for Pharmacogenomic
Assessment (VESPA) to determine SNPs associated both
with disease and pharmacogenomic outcomes [39].
Dr. Ursula Amstutz of the University of British
Columbia presented work from the Canadian Pharmaco-
genomics Network for Drug Safety focusing on reducing
drug harm in children [40]. The current process of vali-
dating drug safety looks at evidence for drug efficacy
and safety at usual doses in populations; however physi-
cians treat individuals, who may have different reactions
to a given drug. When adverse drug effects in children
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due to differences in drug metabolism compared to
adults. Working with children who experience cisplatin
induced hearing loss, they were able to identify two
SNPs that predicted 48% of the cases of hearing loss
[41]. Another study examined anthracycline induced
cardiotoxicity, finding a highly significant SNP that was
validated in a separate group of patients [42]. It is
hoped that identification of these SNPs will lead to pre-
emptive testing to provide guidance in choosing meth-
ods of treatment for children.
Session III: systems biology
Quaid Morris from the University of Toronto led the
final plenary session with a talk titled “Three Degrees
of Propagation for Predicting Gene Function Using
Networks.” In this presentation, Dr. Morris discussed
t h ei d e at h a tb i o l o g i c a li n t eraction networks are in
general “small world” networks with a high degree of
hubs and short paths connecting most nodes. Using
the knowledge that often genes in the same pathway
a r em o r el i k e l yt os h a r en e i g h b o r st h a nt ob ed i r e c t l y
connected, gene function can be better predicted from
functional gene and interaction networks by consider-
ing shared neighbors. Dr. Morris’ group observed that
in general, only three to four degrees of propagation
provides useful information when considering true
gene interactions. After that, every gene in a gene net-
work study is likely to be visited, much in the same
way that the idea of “six degrees of separation” is able
to link together any two different individuals world-
wide within six steps, on average, through “af r i e n do f
af r i e n d ” relationships [43]. This is the process found
in the “K e v i nB a c o ng a m e ” in which participants are
challenged to link a random actor or actress to Kevin
Bacon in six or fewer steps where two actors/actresses
are connected if they appeared in a movie or commer-
cial together [44]. The Morris group has created a new
algorithmic approach, 3Prop, which takes this neigh-
borhood information into account to predict gene
function. 3Prop extends their previous work of predict-
ing gene function given limited annotation information
[11,45]. This approach has been applied to identify the
gender of users of social media sites by positively
weighting their friends’ genders and negatively weight-
ing their friends’ friends’ genders.
The second talk of the session was the final plenary
speaker, David Galas, from the Institute for Systems
Biology who presented “Genetics in the Age of Sequen-
cing: Converging on Complexity.” In this talk, Dr. Galas
discussed the transformation of human genetics as a
result of whole genome sequencing and associated com-
putational approaches. A discussion ensued about the
advances that genome wide association studies (GWAS)
have led into the understanding of complex diseases
[46] , including 1212 published genome-wide associa-
tions for 210 traits as of 12/2010 (http://www.genome.
gov/gwastudies). However, the point was made that
familial-based sequencing can be a powerful technology
for complex disease association, as demonstrated by a
family of four sequencing project in which two siblings
and their parents were sequenced [47]. Dr. Galas dis-
cussed the results of this project which was based on
two recessive Medalian disorders displayed in the sib-
lings: Miller syndrome and primary ciliary dyskinesia. By
looking at familial sequencing, the ability to detect
recombination events with high precision is possible,
which can lead to more directed analysis of disorders at
a genetic level. Dr. Galas expanded upon additional cur-
rent research at the Institute for Systems Biology,
including a multigenerational sequencing project and a
project to sequence 600 individuals (all in families)
focusing on diseases such as Huntington’s and congeni-
tal heart defects.
Posters and short talks
The poster session was held on day two before the main
banquet. Forty-eight posters were on display, all from a
variety of different research areas. A number of posters
were also selected for short talks in each session. The
talks and the presenting authors are listed below for
each session. For full author lists and abstracts see the
rest of the supplement.
Session I
“Contribution of common and rare variants in SLCO1B1
to variation in clearance of methotrexate in acute lym-
phoblastic leukemia patients” (Laura B. Ramsey, St. Jude
Children’s Research Hospital), “Significant Analysis of
Microarray Using Literature (SAMUL)” (Ramin
Homayouni, University of Memphis), “Integrating RNA-
Seq data Improves Protein Identification in Shotgun
Proteomics” (Xiaojing Wang, Vanderbilt University),
“T h eC h a l l e n g e sa n dO p p o r t u n i t i e sF a c i n gu sa sw e
Organize Genetic Research Data for “Meaningful Use"”
(Ted Kalbfleisch, Intrepid Bioinformatics).
Session II
“Integrative Biclustering of Heterogeneous Datasets
using a Bayesian Nonparametric Model with Application
to Chemogenomics” (Dazhuo Li, University of Louis-
ville), “A Statistical Procedure to Evaluate Agreement of
Differential Expression for Translational Cross-Species
Genomics” (Cuilan Gao, St. Jude Children’s Research
Hospital), “Utility of Methylation Biomarkers in Com-
plex Disease” (Gary L Rogers, University of Tennessee -
Knoxville), “Targeted Genotyping for Biomarker Devel-
opment” (Bradford Silver, Computable Genomix).
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“Identify the Key Genes and Pathways in the Progres-
sion of Hepatitis C Virus Induced Hepatocellular Carci-
noma Using a Systems Biology Approach” (Siyuan
Zheng, Vanderbilt University), “Bioinformatics Analysis
of Genome-Wide Differential Gene Expression Patterns
Associated with Differential Susceptibility to Severe
Group A Streptococcal Sepsis” (Nourtan Abdeltawab,
University of Tennessee Health Science Campus),
“Genes Without Borders: A Systematic Survey of Mobile
Genes and Genomes in Environmental Metagenomes”
(Ramy Aziz, San Diego State University), “Design,
Implementation and Uses of the Parabiclique Algo-
rithm” (Charles A. Phillips, University of Tennessee -
Knoxville).
Future plans
The 2012 Bioinformatics summit will return to the state
of Kentucky in the spring of 2012. Potential focus areas
include current technological trends in molecular biol-
ogy, applications of next-generation sequencing, and sys-
tems biology.
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